The analysis demonstrates that routine use of FFR could reduce the number of deaths and heart attacks of German citizens while also saving a potential €14,000,000 in 2011 and 2012.
The study was conducted to determine the incremental cost-effectiveness of FFR-guided vs. angiography-guided PCI in patients with multivessel coronary artery disease in the German health care system from the societal perspective.
To do this, original data from the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) study was used.
The FAME study, which exclusively used the St Jude Medical PressureWire, demonstrated that routine use of FFR in the US would reduce health care costs by about $2,000 per patient as well as provide improved outcomes for patients, including a 34% reduction in death or heart attack after two years.
Results from the economic evaluation are based solely on the use of the St Jude Medical FFR measurement technology, the PressureWire Certus.
